Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126029561 | 12602956 | 1 | I | 20160707 | 20160718 | 20160728 | 20160728 | EXP | GB-MHRA-TPP9964479C403336YC1467912927896 | GB-TEVA-678811ACC | TEVA | 47.00 | YR | F | Y | 116.00000 | KG | 20160728 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126029561 | 12602956 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Buccal | U | U | 77232 | 20 | MG | |||||||
| 126029561 | 12602956 | 2 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Buccal | U | U | 77232 | 10 | MG | |||||||
| 126029561 | 12602956 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 1 DOSAGE FORMS DAILY; | 2714.95833 | DF | 0 | 1 | DF | QD | |||||
| 126029561 | 12602956 | 4 | C | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | 2 DOSAGE FORMS DAILY; | 72 | DF | 0 | 1 | DF | Q12H | |||||
| 126029561 | 12602956 | 5 | C | CODEINE PHOSPHATE | CODEINE PHOSPHATE | 1 | Oral | 4 DOSAGE FORMS DAILY; WHEN NEEDED. | 248 | DF | 0 | 1 | DF | QID | |||||
| 126029561 | 12602956 | 6 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | Oral | 4 DOSAGE FORMS DAILY; IF NEEDED. | 248 | DF | 0 | 1 | DF | QID | |||||
| 126029561 | 12602956 | 7 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Oral | 1 DOSAGE FORMS DAILY; | 1296.95833 | DF | 0 | 1 | DF | QD | |||||
| 126029561 | 12602956 | 8 | C | INDAPAMIDE. | INDAPAMIDE | 1 | Oral | 1 DOSAGE FORMS DAILY; EVERY MORNING | 1543 | DF | 0 | 1 | DF | QD | |||||
| 126029561 | 12602956 | 9 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 1 DOSAGE FORMS DAILY; | 2337.95833 | DF | 0 | 1 | DF | QD | |||||
| 126029561 | 12602956 | 10 | C | REVAXIS | DIPHTHERIA AND TETANUS TOXOIDS AND POLIOVIRUS VACCINE ANTIGENS | 1 | 0 | ||||||||||||
| 126029561 | 12602956 | 11 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | Oral | ONE OR TWO TO BE TAKEN AT NIGHT FOR C... | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126029561 | 12602956 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126029561 | 12602956 | Agitation | |
| 126029561 | 12602956 | Feeling hot | |
| 126029561 | 12602956 | Hyperhidrosis | |
| 126029561 | 12602956 | Mood altered | |
| 126029561 | 12602956 | Serotonin syndrome | |
| 126029561 | 12602956 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126029561 | 12602956 | 3 | 20090130 | 0 | ||
| 126029561 | 12602956 | 4 | 20160601 | 20160608 | 0 | |
| 126029561 | 12602956 | 5 | 20160506 | 20160603 | 0 | |
| 126029561 | 12602956 | 6 | 20160506 | 20160531 | 0 | |
| 126029561 | 12602956 | 7 | 20121218 | 0 | ||
| 126029561 | 12602956 | 8 | 20120416 | 0 | ||
| 126029561 | 12602956 | 9 | 20100211 | 0 | ||
| 126029561 | 12602956 | 10 | 20160428 | 20160429 | 0 | |
| 126029561 | 12602956 | 11 | 20160506 | 20160605 | 0 |